Excelsyn chases process improvement
Excelsyn Molecular Development claims to have made a "major advance" in a protein intensification process that can be used to slash the manufacturing costs of a range of amino acids.
Archives for October 15, 2006
Indena steps up efforts in "natural drug" market
Italian pharma company Indena is strengthening its position in the "natural drug" market - where drug molecules are derived from plants - a potentially lucrative niche area of pharmaceuticals.
Information Technology hailed as tool to streamline trials
There is a growing realisation in pharma that, to remain competitive, paper-based trials are not the way forward. Instead, electronic data capture (EDC) and management technology solutions are now readily available and becoming more broadly adopted.
Sandoz wades deeper into generic biopharmaceuticals
As it looks to the "future of pharmaceuticals," Sandoz is planning a "powerful biopharmaceuticals programme" with the construction of a new biopharmaceuticals development centre in Ljubljana, Slovenia.
Pharma firms manufacturing waste costs $50bn, report warns
The US pharmaceutical industry could be wasting more than $50bn (€39bn) per year in manufacturing costs due to inefficient processes, a new research has warned.
External sourcing fuelling mid pharma development
By 2010 nearly half of all mid pharma firm revenues will be derived from products that have been discovered outside of in-house development pipelines, says a new report from independent market analyst Datamonitor.